Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study

Carbohydrate antigen 19-9 after induction therapy, carbohydrate antigen 19-9 decrease, and performance status are independent prognostic factors for overall survival after surgical exploration for locally advanced pancreatic cancer. Three-year overall survival is best in patients with a performance status of zero, a greater than 80% decrease in carbohydrate antigen 19-9, and a post-induction carbohydrate antigen 19-9 level less than 50 U/ml.

Authors

Institutions

Publication Details

Journal
British journal of surgery
Published
2025-02-01
DOI
https://doi.org/10.1093/bjs/znaf011
Citations
2
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study

Alice C. Wei, L.R. Prakash, Roeland F. de Wilde, David van Klaveren et al.
2 citations
British journal of surgery
Pancreatic and Hepatic Oncology Research
2.09
article

Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study

Alice C. Wei, L.R. Prakash, Roeland F. de Wilde, David van Klaveren, Crisanta Ilagan, Matthew H. G. Katz, Marc G. Besselink, Dana Haviland, Bas Groot Koerkamp, Alessandro Paniccia, Sarah J. McIntyre, Amer H. Zureikat, Quisette P. Janssen, Amila O. De Silva, Eileen Mary O'Reilly, Ching‐Wei D. Tzeng, Esther N. Dekker, Eva M M Verkolf, Rutger T. Theijse, Rudy El Asmar
article en
2 citations

Abstract

Carbohydrate antigen 19-9 after induction therapy, carbohydrate antigen 19-9 decrease, and performance status are independent prognostic factors for overall survival after surgical exploration for locally advanced pancreatic cancer. Three-year overall survival is best in patients with a performance status of zero, a greater than 80% decrease in carbohydrate antigen 19-9, and a post-induction carbohydrate antigen 19-9 level less than 50 U/ml.

British journal of surgeryVol. 112(2)
Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Erasmus MC (NL), University of Pittsburgh Medical Center (US), Erasmus MC Cancer Institute (NL), Amsterdam University Medical Centers (NL), University of Amsterdam (NL)
ZonMw, KWF Kankerbestrijding
Life below water
Openalex Percentile: Top 14%
Pancreatic and Hepatic Oncology Research
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.